Green Alpha Advisors, LLC Ab Cellera Biologics Inc. Transaction History

Green Alpha Advisors, LLC

$124 Million
Q3 2024

A detailed history of Green Alpha Advisors, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Green Alpha Advisors, LLC holds 48,515 shares of ABCL stock, worth $133,901. This represents 0.1% of its overall portfolio holdings.

Number of Shares

48,515

Previous 24,709 96.35%

Holding current value

$133,901

Previous $73,000 71.23%

% of portfolio

0.1%

Previous 0.06%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$2.39 - $3.49 $56,896 - $83,082	23,806 Added 96.35%	48,515 $125,000
Q2 2024 Aug 13, 2024	SELL	$2.73 - $4.73 $9,931 - $17,207	-3,638 Reduced 12.83%	24,709 $73,000
Q1 2024 Apr 09, 2024	BUY	$4.29 - $5.97 $2,230 - $3,104	520 Added 1.87%	28,347 $128,000
Q4 2023 Jan 04, 2024	SELL	$3.91 - $5.93 $45,109 - $68,414	-11,537 Reduced 29.31%	27,827 $158,000
Q3 2023 Oct 10, 2023	SELL	$4.6 - $7.95 $69,234 - $119,655	-15,051 Reduced 27.66%	39,364 $181,000
Q2 2023 Jul 06, 2023	BUY	$5.66 - $7.59 $37,763 - $50,640	6,672 Added 13.97%	54,415 $351,000
Q1 2023 Apr 06, 2023	SELL	$7.31 - $11.18 $6,944 - $10,621	-950 Reduced 1.95%	47,743 $359,000
Q4 2022 Jan 12, 2023	SELL	$9.48 - $14.52 $4,275 - $6,548	-451 Reduced 0.92%	48,693 $0
Q3 2022 Oct 14, 2022	SELL	$9.2 - $13.68 $4,112 - $6,114	-447 Reduced 0.9%	49,144 $486,000
Q2 2022 Jul 08, 2022	BUY	$5.72 - $10.65 $89,106 - $165,905	15,578 Added 45.8%	49,591 $528,000
Q1 2022 Apr 19, 2022	BUY	$7.46 - $14.14 $43,611 - $82,662	5,846 Added 20.75%	34,013 $332,000
Q4 2021 Jan 12, 2022	BUY	$12.99 - $17.73 $51,687 - $70,547	3,979 Added 16.45%	28,167 $403,000
Q3 2021 Oct 12, 2021	BUY	$14.85 - $21.34 $359,191 - $516,171	24,188 New	24,188 $485,000

Others Institutions Holding ABCL

# of Institutions

153

Shares Held

109M

Call Options Held

153K

Put Options Held

194K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Alpha Advisors, LLC with notifications on news.

Account

Green Alpha Advisors, LLC Ab Cellera Biologics Inc. Transaction History